Literature DB >> 2117786

Enterocytozoon bieneusi (Microspora): prevalence and pathogenicity in AIDS patients.

E U Canning1, W S Hollister.   

Abstract

Microsporidia are unicellular organisms, which lack mitochondria. They have prokaryotic-like ribosomes and characteristic spores containing an extrusible polar tube which serves as a passage for inoculation of the infectious agent (sporoplasm) into host cells. Clinically apparent infections in man appear to be limited to immunoprivileged sites or immunocompromised patients. One species, Encephalitozoon cuniculi, has been reported several times in patients with neurological disorders and once causing a fatal hepatitis in an AIDS patient. The most recently discovered species, Enterocytozoon bieneusi, is known only from the small intestinal enterocytes of patients with the acquired immunodeficiency syndrome, and is easily differentiated from other microsporidia by the precocious development of spore organelles in the sporont and by the poor development of the endospore layer of the spore wall. Although only about 40 cases have been reported, circumstantial evidence suggests that E. bieneusi may be the cause of a severe watery diarrhoea, which responds only temporarily to treatment with metronidazole.

Entities:  

Mesh:

Year:  1990        PMID: 2117786     DOI: 10.1016/0035-9203(90)90247-c

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  24 in total

1.  Use of electron microscopy in examination of faeces and rectal and jejunal biopsy specimens.

Authors:  G M Connolly; D S Ellis; J E Williams; G Tovey; B G Gazzard
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

2.  Histological diagnosis of intestinal microsporidiosis in patients with AIDS.

Authors:  C S Peacock; C Blanshard; D G Tovey; D S Ellis; B G Gazzard
Journal:  J Clin Pathol       Date:  1991-07       Impact factor: 3.411

3.  Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber's modified trichrome and Uvitex 2B strains.

Authors:  P C DeGirolami; C R Ezratty; G Desai; A McCullough; D Asmuth; C Wanke; M Federman
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

4.  Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Authors:  Quanshun Zhang; Inderpal Singh; Abhineet Sheoran; Xiaochuan Feng; John Nunnari; Angela Carville; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Developmental expression of two spore wall proteins during maturation of the microsporidian Encephalitozoon intestinalis.

Authors:  J R Hayman; S F Hayes; J Amon; T E Nash
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Incidental finding of a microsporidian parasite from an AIDS patient.

Authors:  R J McDougall; M W Tandy; R E Boreham; D J Stenzel; P J O'Donoghue
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 7.  Parasitic infections of the small intestine.

Authors:  J Jernigan; R L Guerrant; R D Pearson
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

8.  Detection of microsporidia by indirect immunofluorescence antibody test using polyclonal and monoclonal antibodies.

Authors:  A M Aldras; J M Orenstein; D P Kotler; J A Shadduck; E S Didier
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens.

Authors:  N J Ryan; G Sutherland; K Coughlan; M Globan; J Doultree; J Marshall; R W Baird; J Pedersen; B Dwyer
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

Review 10.  Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases.

Authors:  C Franzen; G Fätkenheuer; B Salzberger; A Müller; G Mahrle; V Diehl; M Schrappe
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.